Edwards Lifesciences Corporation EW
Strong Medical Devices & Diagnostics sector · Edwards Lifesciences — leader in transcatheter heart valves (TAVR) with a structural-heart pipeline.
Edwards Lifesciences Corporation (EW) is an established Medical Devices & Diagnostics company, graded Strong on FrontierLab's evidence-based quality rubric (data as of 2026-08-21). Revenue grew 14.6% year-over-year at a 78% gross margin. Gross-profits-to-assets is 0.37; Rule of 40 is 42.7. Net share issuance -1.8% YoY (flat share count). No risk flags are currently noted. Analyst mix: 30 buy / 10 hold / 0 sell.
These sentences are generated from the day's data by deterministic templates.
Key quality signals
| Revenue growth (YoY) | 14.6% |
|---|---|
| Gross margin | 78% |
| Gross profits / assets | 0.37 |
| Rule of 40 | 42.7 |
| Net margin | 28.1% |
| Cash runway (months) | — |
| PEG | — |
| Price / sales | 7.9 |
Quality checklist
Each line is one quality test behind the grade — ✓ passed · ~ borderline · ✗ failed. Hover a metric in the tables below for what it means.
- ~ Revenue growth — 14.6% (pass ≥ 20%)
- ✓ Gross profits / assets — 0.37 (pass ≥ 0.33)
- · Rule of 40 — 42.7 (context — graded for software only)
- ✓ Gross margin — 78% (pass ≥ 60% · Medical Devices & Diagnostics)
- ✓ Cash generation
- ✓ Share dilution — -1.8%
- ✓ Competitive moat — Wide
- ✓ Market size (TAM) — Large
Grade history
Graded Strong since 2026-06-17 — no grade changes recorded yet.
How have Strong-graded names performed?
The forward returns of all Strong-graded names since each grade was recorded — the bucket this name currently sits in, not a forecast of this individual stock.
| Window | Forward record vs the S&P | Median |
|---|---|---|
| ~1 month | 59% of Strong-graded names beat the S&P over 21 sessions (95% CI 41–74%, N=29). | Median excess vs the S&P was +4.2%. |
| ~3 months | building — 13 more sessions needed | |
| ~6 months | building — 76 more sessions needed | |
Scope: these are forward returns vs the S&P among names still covered at each horizon's end, within the curated universe — not a survivorship-clean whole-market backtest. Names later dropped from coverage are counted as attrition (not hidden), and single-session moves beyond ±300% are treated as split/data artifacts and excluded. How this is measured → · Full track record →
How it compares
Coarse same-sector, same-stage context — not a percentile or rank. GP/A is graded on its absolute level, not position.
Fundamentals
| Market cap | $51.72B |
|---|---|
| Stage | Established |
| Share issuance (YoY) | -1.8% · flat share count |
| Moat | Wide |
| TAM | LARGE |
| P/E (trailing) | 51.6 |
| EPS (trailing) | $1.74 |
| Burn multiple | — |
| Gross-margin trend (pts) | -0.9 |
| Cash / assets | 0.31 |
| Accruals (%) | -5.2% |
| Net debt / EBITDA | -1.4 |
| Statements as of | Q2 FY2026 · filed 2026-08-04 |
Momentum context — describes the past, not a signal
Low reached Oct 16, 2025 · high reached Jul 6, 2026 — by daily close.
| Price | $89.83 (as of 2026-08-20) |
|---|---|
| Last session move | — |
| % off 52-wk high | -6.7% |
| RSI (14) | 51 |
| Relative volume | 0.7× |
Insider activity (90 days)
| Cluster buyers | 0 |
|---|---|
| Sellers | 5 |
Insider selling is routine diversification, not a bearish signal.
Analyst mix
| Strong buy | 13 |
|---|---|
| Buy | 17 |
| Hold | 10 |
| Sell | 0 |
| Strong sell | 0 |
• Coverage changed — coverage 42→40 analysts over ~4 weeks (per aggregated analyst ratings)
Ratings are context, not a price target. "Momentum" = how the mix changed over recent weeks, not a forecast.
From the headlines
AI take — daily, AI-generated
AI leans mixed
Strong growth, exceptional 78% margins, and solid GP/A, but missing PEG data and no recent catalysts make it hard to assess value; 100% bullish sentiment alone isn't enough.
Generated by an AI model from the day's news — an opinion for context only. Not financial advice, not a recommendation, and not a price target.
Similar Medical Devices & Diagnostics names
← All Medical Devices & Diagnostics names · Open EW in the interactive screener →
Data as of 2026-08-21 08:12 (end-of-day). How grades are computed →